Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial

The Lancet Haematology 2026

View at publisher
Authors: Valentín Ortiz-Maldonado, Nuria Martínez-Cibrian, Letícia Alserawan, Marta Español‐Rego, Sergio Navarro-Velázquez, Nil Albiol, A. Oliver-Caldés, Ana Triguero, María Virginia Herrero-García, Sara Gutiérrez-Herrero, Daniel Benitez-Ribas, María Liz Paciello
+35 more Anna Torrent, Javier Delgado-Serrano, María Sánchez-Castañón, Hugo Calderón, Juan José Mata, Andres Sanchez-Salinas, Joaquín Sáez-Peñataro, Carla Sans‐Pola, Maria Calvo-Orteu, Lucía Lopez-Corral, Mi Kwon, José Rifón, Paola Charry, Rafael Alberto Alonso-Fernández, María Huguet, Cristina Blázquez-Goñi, José María Sanchez-Pina, Ricardo Sánchez, Juan Manuel Rosa-Rosa, Joaquin Martinez-Lopez, Miguel Blanquer, Josep Ribera, Álvaro Urbano-Ispizua, Mireia Bachiller, Laura Palau, Eulàlia Olesti, Gonzalo Calvo, Lourdes Martín‐Martín, Alberto Orfao, E Azucena González-Navarro, Gemma Domenech, Sara Varea, Manel Juan, Julio Delgado, Jordi Esteve
DOI: 10.1016/s2352-3026(25)00328-x
Cited by: 4
References: 30

Fields of Study & Subjects

Acute Lymphoblastic Leukemia research CAR-T cell therapy research Immunotherapy and Immune Responses

Publication details

Journal / source
The Lancet Haematology
Publisher
Elsevier BV
Volume
13
Issue
3
Pages
e133–e143
Publication date
3 February 2026
Language
EN